• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺移植受者中 SARS-CoV-2 体液和细胞免疫的持续缺陷。

Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.

机构信息

Chest Department, Hôpital Universitaire de Bruxelles Erasme, Université Libre de Bruxelles, Brussels, Belgium; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium.

European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium; Department of Nephrology, Dialysis and Transplantation, Hôpital Universitaire de Bruxelles Erasme, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

J Heart Lung Transplant. 2024 Nov;43(11):1857-1860. doi: 10.1016/j.healun.2024.08.002. Epub 2024 Aug 10.

DOI:10.1016/j.healun.2024.08.002
PMID:39134165
Abstract

Lung transplant recipients (LTRs) are susceptible to severe Coronavirus Disease 2019 (COVID-19) and had lower immune responses to primary severe acute respiratory syndrome-related to coronavirus 2 (SARS-CoV-2) vaccination as compared to the general population and to other solid organ transplant recipients. As immunity induced by booster vaccination and natural infection has increased since the beginning of the pandemic in the general population, immunity acquired by LTRs is not well documented. Humoral and cellular immunity to SARS-CoV-2 was monitored in February and May 2023 in 30 LTRs and compared to that of health care workers (HCWs) and nursing home residents (NHRs). LTRs had significantly lower levels of SARS-CoV-2 binding and neutralizing antibodies and lower interferon-gamma responses to Wuhan, Delta, and XBB1.5 variants as compared to HCWs and NHRs. Humoral immunity decreased between the 2 visits, whereas cellular immunity remained more stable. The persistent defect in SARS-CoV-2 immunity in LTRs should encourage continued monitoring and preventive measures for this vulnerable population.

摘要

肺移植受者(LTR)易感染严重的 2019 年冠状病毒病(COVID-19),并且与一般人群和其他实体器官移植受者相比,对原发性严重急性呼吸综合征相关冠状病毒 2(SARS-CoV-2)疫苗的免疫反应较低。由于自大流行开始以来,普通人群中由加强疫苗接种和自然感染引起的免疫反应有所增加,因此 LTR 获得的免疫反应尚未得到很好的记录。在 2023 年 2 月和 5 月监测了 30 名 LTR 对 SARS-CoV-2 的体液和细胞免疫,并将其与医护人员(HCWs)和养老院居民(NHRs)进行了比较。与 HCWs 和 NHRs 相比,LTR 对武汉、Delta 和 XBB1.5 变体的 SARS-CoV-2 结合和中和抗体水平以及干扰素-γ反应明显较低。体液免疫在两次就诊之间下降,而细胞免疫保持更稳定。LTR 中 SARS-CoV-2 免疫的持续缺陷应鼓励对这一脆弱人群进行持续监测和预防措施。

相似文献

1
Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.肺移植受者中 SARS-CoV-2 体液和细胞免疫的持续缺陷。
J Heart Lung Transplant. 2024 Nov;43(11):1857-1860. doi: 10.1016/j.healun.2024.08.002. Epub 2024 Aug 10.
2
mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells.mRNA 疫苗接种 COVID-19 对有 SARS-CoV-2 既往感染的肺移植受者诱导持久的 SARS-CoV-2 特异性抗体和 T 细胞。
Vaccine. 2024 Oct 24;42(24):126250. doi: 10.1016/j.vaccine.2024.126250. Epub 2024 Sep 2.
3
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients.抗代谢药物方案对实体器官移植受者接种 SARS-CoV-2 疫苗后细胞和体液免疫应答的影响。
Immunol Lett. 2024 Aug;268:106886. doi: 10.1016/j.imlet.2024.106886. Epub 2024 Jun 19.
4
Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.肾移植受者和透析患者对 SARS-CoV-2 的体液免疫:SARS-CoV-2 感染和接种疫苗后解析的 IgA 和 IgG 模式。
Virol J. 2024 Jun 13;21(1):138. doi: 10.1186/s12985-024-02410-1.
5
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.心脏和胸部移植受者对两剂 SARS-CoV-2 信使 RNA 疫苗 BNT162b2 的体液和 T 细胞应答较差。
Clin Res Cardiol. 2021 Aug;110(8):1142-1149. doi: 10.1007/s00392-021-01880-5. Epub 2021 Jul 9.
6
Augmented humoral response to third and fourth dose of SARS-CoV-2 mRNA vaccines in lung transplant recipients.肺移植受者对 SARS-CoV-2 mRNA 疫苗第三和第四剂加强的体液免疫反应。
Respir Investig. 2024 Sep;62(5):804-810. doi: 10.1016/j.resinv.2024.07.004. Epub 2024 Jul 13.
7
Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters.多元化的体液免疫和加强疫苗的影响:初次或第二次加强针前后 SARS-CoV-2 抗体特征和奥密克戎 BA.2 的中和作用。
Microbiol Spectr. 2024 Oct 3;12(10):e0060524. doi: 10.1128/spectrum.00605-24. Epub 2024 Aug 20.
8
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.mRNA 疫苗接种后肾移植受者对 SARS-CoV-2 奥密克戎亚变种的中和抗体反应和细胞反应。
Sci Rep. 2024 May 28;14(1):12176. doi: 10.1038/s41598-024-63147-z.
9
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
10
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients.肝移植受者第三次和第四次 SARS-CoV-2 mRNA 疫苗接种后的体液和细胞免疫反应。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2558-2566.e5. doi: 10.1016/j.cgh.2022.06.028. Epub 2022 Jul 16.

引用本文的文献

1
Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation.鉴定与SARS-CoV-2感染和肺移植相关的免疫特征。
Cell Rep Med. 2025 Aug 19;6(8):102262. doi: 10.1016/j.xcrm.2025.102262. Epub 2025 Jul 31.